Croda International (FRA:6CMB) Research & Development: €0 Mil (TTM As of Dec. 2025)


FRA:6CMB Croda International PLC FRA:6CMB
69 GF Score
Price €35.54
GF Value €47.33
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Croda International Research & Development?

Croda International FRA:6CMB -0.62% 69 Research & Development is €0 Mil as of Dec. 2025. GuruFocus rates FRA:6CMB with a GF Score™ of 69/100 and a GF Value™ of €47.33 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Croda International's Research & Development for the six months ended in Dec. 2025 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0 Mil.

Croda International  (FRA:6CMB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Croda International Research & Development Related Terms

Croda International Research & Development Historical Data

* Premium members only.

The historical data trend for Croda International's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Croda International Research & Development Chart

Croda International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Croda International Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:6CMB
69GF Score
Croda International PLC FRA:6CMB
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Croda International Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Croda International (FRA:6CMB) has a Research & Development of €0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Croda International and its competitors.
Is Croda International's Research & Development too high?
Croda International's current Research & Development is €0 Mil. Overall, Croda International has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Croda International's Research & Development compare to LIN and SHW?
Croda International's Research & Development of €0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Croda International and its competitors. Croda International's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Croda International stock overvalued right now?
Based on GuruFocus' analysis, Croda International (FRA:6CMB) is currently considered Modestly Undervalued. The stock's GF Value™ is €47.33, compared to a current price of €35.54 — trading 24.9% below its estimated fair value. The current Research & Development is €0 Mil. Croda International's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Croda International (FRA:6CMB), the current Research & Development is €0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Croda International (FRA:6CMB) Overvalued in 2026?

Based on GuruFocus' analysis, Croda International stock appears to be undervalued. The current stock price of €35.54 is trading 24.9% below its estimated GF Value™ of €47.33. GuruFocus considers Croda International to be Modestly Undervalued.

Key valuation signals for FRA:6CMB:

  • Research & Development: €0 Mil
  • GF Value™: €47.33 vs. price of €35.54 (24.9% below fair value)
  • GF Score™: 69/100 with 8 warning signs

No single metric tells the full story. See the FRA:6CMB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Croda International Business Description

Address Cowick Hall, Snaith, Goole, East Yorkshire, GBR, DN14 9AA
Croda is a British specialty chemicals company with 60% of sales outside Europe. Croda operates through three segments: consumer care, life sciences, and industrial specialties. Consumer care produces specialty and active ingredients for cosmetics and skincare/haircare and also flavors and fragrances. The life sciences business manufactures products for healthcare and agrochemicals. The company sold the majority of its industrial businesses to Cargill in 2022, retaining only a subsegment of the business (industrial specialties segment) that supports the other two segments and sells their byproducts.
69GF Score

Get the complete analysis for FRA:6CMB

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€35.54
Price
€47.33
GF Value